ethyl 2-hydroxy-4-(2-nitrophenyl)-4-oxobut-2-enoate, 98%, 500mg

HSA-Lewis X1vial

2-(3-Methylphenyl)malondialdehyde, 95.0%, 5g

1-Butyl-3-methylpyridinium Chloride, 98.0%, 5g

4-BROMO-2-(PYRROLIDIN-1-YL)THIAZOLE, 95.0%, 1g

Sodium octadecyl sulfate, 98%, 5g

2-Chloro-5-methylnicotinamide, 95+%, 1g

Sealing foil for microtiter plates Polyester, Non-sterile, 25 µm 100 pcs

ethyl 2-naphthylacetate, 1g

2,7-Dichlorothiazolo[5,4-c]pyridine, 95.0%, 5g

1-tert-butyl 3-methyl 3-hydroxyazetidine-1,3-dicarboxylate, 97.0%, 500mg

5-Bromo-2-methoxynicotinaldehyde, 98.0%, 1g

1,4-Bis(chloromethyl)tetrafluorobenzene, 96.0%, 5g